Abstract
Purpose
This retrospective study analyzed the results of 23G vitrectomy for the treatment of intraocular hemorrhage in patients with Terson syndrome. The pathogenesis of Terson syndrome and the timing of vitrectomy are discussed.
Methods
Eight eyes of eight patients were included in the study. Intrasurgical images were acquired, and membranes peeled off during surgery were subjected to pathological staining. Postoperative examination included visual acuity, intraocular pressure, funduscopy, and optical coherence tomography angiography.
Results
The course of visual impairment in the patients ranged from < 1 to 5 months; visual acuity ranged from light perception to 20/1000. Surgeries in the eight patients were all successful, and no severe complications were observed. Visual acuity improved in each operative eye. Pathological staining revealed only fibrous connective tissue, and no nerve fibers in the membranes peeled off during surgery. Optical coherence tomography angiography revealed no changes in blood vessel density in the inner layer of the retina of the operative eye compared with the non-operative eye in each patient.
Conclusions
Timely surgical intervention is necessary for the treatment of intraocular hemorrhage in patients with Terson syndrome. Clinical findings support the theory that intraocular blood results from stasis or rupture of retinal superficial peripapillary vessels caused by elevated intracranial pressure.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Litten M (1881) Ueber Einige von Allgemein-Klinischen Standpunkt aus Interessante Augenveränderungen. Berl Klin Wochenschr 18:23–37
De Terson A (1990) L´hemorrhagie dans le corps vitre au cours de l´hemorrhagie cerebrale. Clin Ophthalmo 6:309–312
Kuhn F, Morris R, Witherspoon CD, Mester V (1998) Terson syndrome. Results of vitrectomy and the significance of vitreous hemorrhage in patients with subarachnoid hemorrhage. Ophthalmology 105:472–477
Pfausler B, Belcl R, Metzler R, Mohsenipour I, Schmutzhard E (1996) Terson’s syndrome in spontaneous subarachnoid hemorrhage: a prospective study in 60 consecutive patients. J Neurosurg 85:392–394
Ogawa T, Kitaoka T, Dake Y, Amemiya T (2001) Terson syndrome: a case report suggesting the mechanism of vitreous hemorrhage. Ophthalmology 108:1654–1656
Czorlich P, Skevas C, Knospe V, Vettorazzi E, Richard G, Wagenfeld L et al (2015) Terson syndrome in subarachnoid hemorrhage, intracerebral hemorrhage, and traumatic brain injury. Neurosurg Rev 38:129–1236
Nacef L, Zghal-Mokni I, Allagui I, Haba B, Daghfous F, Gaigi S et al (2004) Indications and results of vitrectomy in Terson syndrome. Tunis Med 82:461–464
Garweg JG, Koerner F (2009) Outcome indicators for vitrectomy in Terson syndrome. Acta Ophthalmol 87:222–226
Riddoch G, Goulden C (1925) On the relationship between subarachnoid and intraocular haemorrhage. Br J Ophthalmol 9:209–233
Castren JA (1963) Pathogenesis and treatment of Terson syndrome. Acta Ophthalmol 41:430–434
Ballantyne AJ (1943) The ocular manifestations of spontaneous subarachnoid haemorrhage. Br J Ophthalmol 27:383–414
Vanderlinden RG, Chisholm LD (1974) Vitreous hemorrhages and sudden increased intracranial pressure. J Neurosurg 41:167–176
Dörner L, Affke K, Barth H, Mehdorn HM (2009) A subarachnoid haemorrhage primarily presenting as Terson’s syndrome. Cent Eur Neurosurg 70:82–90
Middleton K, Esselman P, Lim PC (2012) Terson syndrome: an underrecognized cause of reversible vision loss in patients with subarachnoid hemorrhage. Am J Phys Med Rehabil 91:271–274
Lee Sang-Hee, Seo Jeong-Hwan, Sung-Hee Park Yu, Won Hui, Ko Myoung-Hwan (2015) Terson syndrome in aneurysmal subarachnoid hemorrhage: a case report. Ann Rehabil Med 39:640–644
Evans LP, Newell EA, Mahajan M, Tsang SH, Ferguson PJ, Mahoney J et al (2018) Acute vitreoretinal trauma and inflammation after traumatic brain injury in mice. Ann Clin Transl Neurol 5:240–251
Nazarali S, Kherani I, Hurley B, Williams G, Fielden M, Adatia F et al (2019) Outcomes of vitrectomy in Terson syndrome: a multicenter Canadian perspective. Retina. https://doi.org/10.1097/iae.0000000000002570
Muslubas IS, Karacorlu M, Hocaoglu M, Ersoz MG, Arf S (2018) Anatomical and functional outcomes following vitrectomy for dense vitreous hemorrhage related to Terson syndrome in children. Graefes Arch Clin Exp Ophthalmol 256(3):503–510
Narayanan R, Taylor SC, Nayaka A, Deshpande R, St Aubin D, Hrisomalos FN et al (2017) Visual outcomes after vitrectomy for Terson syndrome secondary to traumatic brain injury. Ophthalmology 124(1):118–122
Liu X, Yang L, Cai W, Gao L, Li Y (2019) Clinical features and visual prognostic indicators after vitrectomy for Terson syndrome. Eye (Lond). https://doi.org/10.1038/s41433-019-0547-3
Passemard M, Koehrer P, Juniot A, Bron AM, Creuzot-Garcher C (2012) Maintenance of anticoagulant and antiplatelet agents for patients undergoing peribulbaranesthesia and vitreoretinal surgery. Retina 32:1868–1873
Kobayashi H (2010) Evaluation of the need to discontinue antiplatelet and anticoagulant medications before cataract surgery. J Cataract Refract Surg 36:1115–1119
Acknowledgements
The authors would like to thank Dr. Jay Stewart for his assistance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ju, C., Li, S., Huang, C. et al. Clinical observations and considerations in the treatment of Terson syndrome using 23G vitrectomy. Int Ophthalmol 40, 2185–2190 (2020). https://doi.org/10.1007/s10792-020-01399-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-020-01399-0